Amarin Corporation plc (NASDAQ:AMRN) has scheduled a conference call for 4th August 2020 at 7:30 AM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.amarincorp.com
Earnings Expectation
Amarin Corporation plc is reporting second quarter financial results on Tuesday 4th August 2020, before market open.
According to analysts surveyed by Thomson Reuters, AMRN is expected to report 2Q20 loss of $ 0.07 per share from revenue of $ 149.48 million.
For the full year, analysts anticipate top line of $ 669.69 million, while looking forward to loss of $ 0.13 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 650.00 million ~ $ 700.00 million
Click Here For More Historical Outlooks Of Amarin Corporation plc
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The companys lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels.
